Bolt Biotherapeutics, Inc. (BOLT) Insider Trading

Name: Bolt Biotherapeutics, Inc. (BOLT) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 21, 2026): Yonehiro Grant (Chief Operating Officer): Sale of 1,417 shares, $5.3K.

Get alerted when insiders trade BOLT

Email address

Loading company data...

Beta

Loading company details...

Beta